American Century Companies’s Amicus Therapeutics FOLD Stock Holding History

American Century Companies's FOLD Position: Q1 2026 in Review

American Century Companies increased its Amicus Therapeutics (FOLD) stake by 99% in Q1 2026, buying an estimated $494K and bringing the position to 69,479 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

American Century Companies first reported a position in FOLD in Q1 2016 and has held it in 26 quarters since. The position peaked at $65M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

• American Century Companies held 69,479 shares of Amicus Therapeutics worth $1M as of Q1 2026.
• American Century Companies bought 34,489 Amicus Therapeutics shares in Q1 2026, an estimated $494K.
• Amicus Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2328 holding.
• American Century Companies first reported a position in Amicus Therapeutics in Q1 2016 and has held it in 26 quarters since.
• American Century Companies's Amicus Therapeutics position peaked at $65M in Q4 2023.
• 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.